Cumberland Pharmaceuticals CPIX Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's total cost of revenue?
- Cumberland Pharmaceuticals (CPIX) reported total cost of revenue of $1.93M in Q1 2026.
- How has Cumberland Pharmaceuticals's total cost of revenue changed year-over-year?
- Cumberland Pharmaceuticals's total cost of revenue increased by 35.6% year-over-year, from $1.43M to $1.93M.
- What is the long-term trend for Cumberland Pharmaceuticals's total cost of revenue?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's total cost of revenue has grown at a -6.7% compound annual growth rate (CAGR), from $8.81M to $6.67M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.